Dube Eric M

CIK 00017634942 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001763494

Recent Transactions

50 trades

Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-10-29$30.12/sh−27,128→ 419,173 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-10-29−27,128→ 180,000 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-10-29$15.46/sh+27,128→ 446,301 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-10-28$30.38/sh−92,872→ 419,173 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-10-28−92,872→ 207,128 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-10-28$15.46/sh+92,872→ 512,045 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-05-05$21.05/sh−18,924→ 419,173 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-05-02+18,924→ 438,097 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Performance-based restricted stock units
2025-05-02−18,924→ 18,924 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-11$24.04/sh−11,375→ 419,173 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-03$20.21/sh−50,691→ 430,548 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-01-31+130,000→ 481,239 total
Award
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-01-31+260,000→ 260,000 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-01-22$19.46/sh−10,736→ 351,239 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-09-09$11.52/sh−21,125→ 361,975 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-09-05+32,500→ 383,100 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-02-01$8.53/sh−9,106→ 360,616 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-02-01$8.86/sh−10,016→ 350,600 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-01-31+135,000→ 369,722 total
Award
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2024-01-31+360,000→ 360,000 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-01-23$8.96/sh−7,873→ 234,722 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-09-05$14.71/sh−4,455→ 242,595 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-08-31+9,900→ 247,050 total
Award
OnKure Therapeutics, Inc.$OKUR
Stock Option (right to buy)
2023-06-06+17,500→ 17,500 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-02-01$22.25/sh−8,196→ 237,150 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-01-31+97,500→ 245,346 total
Award
Travere Therapeutics, Inc.$TVTX
Performance-based restricted stock units
2023-01-31+32,500→ 32,500 total
Award
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2023-01-31+260,000→ 260,000 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-01-24$21.50/sh−6,442→ 147,846 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-01-05$20.75/sh−5,625→ 154,288 total
Award
OnKure Therapeutics, Inc.$OKUR
Stock Option (right to buy)
2022-06-01+17,500→ 17,500 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2022-02-10$27.84/sh−4,832→ 159,913 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2022-01-31+37,848→ 169,558 total
Award
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2022-01-31+169,552→ 169,552 total
Award
Travere Therapeutics, Inc.$TVTX
Performance-based restricted stock units
2022-01-31+37,848→ 37,848 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2022-01-31$27.40/sh−4,813→ 164,745 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2022-01-24$24.98/sh−7,873→ 131,710 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2022-01-05$29.84/sh−10,361→ 141,722 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2022-01-05$30.48/sh−2,139→ 139,583 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2022-01-04$30.43/sh−4,832→ 152,083 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-08-17$17.12/sh−7,836→ 156,915 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-08-13+17,500→ 164,751 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-06-02$14.35/sh−4,780→ 147,251 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-06-01$14.89/sh−4,782→ 152,031 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-02-08$31.58/sh−4,813→ 156,813 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-02-05$31.41/sh−4,813→ 161,626 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-02-03+17,500→ 166,439 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-02-03$28.91/sh−2,406→ 148,939 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-02-02$30.75/sh−2,406→ 151,345 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-02-02$29.60/sh−6,328→ 153,751 total

Companies

Recent Filings

Address

C/O TRAVERE THERAPEUTICS, INC. 3611 VALLEY CENTRE DR., SUITE 300

SAN DIEGO, CA, 92130

View on SEC.gov